Complications From Inflammatory Bowel Disease During Pregnancy and Delivery

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 11, 2012, Pages 1246-1252

  Bröms, Gabriella ^a   Granath, Fredrik ^a   Linder, Marie ^a   Stephansson, Olof ^a   Elmberg, Maria ^a   Kieler, Helle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

IBD; Inflammation; Pregnant; Remission

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; BETAMETHASONE; BUDESONIDE; ETANERCEPT; GLUCOCORTICOID; HYDROCORTISONE; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; MERCAPTOPURINE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANTEPARTUM HEMORRHAGE; ARTICLE; CESAREAN SECTION; COHORT ANALYSIS; COLON RESECTION; CROHN DISEASE; DELIVERY; DISEASE ACTIVITY; DISEASE EXACERBATION; EMERGENCY SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PERINEUM INJURY; POPULATION RESEARCH; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; SMALL INTESTINE RESECTION; THYROID DISEASE; TREATMENT RESPONSE; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

ADULT; CESAREAN SECTION; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; SWEDEN; UTERINE HEMORRHAGE; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84867676372     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.08.018     Document Type: Article

References (35)

1. Molodecky N.A., Soon I.S., Rabi D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
2. Nguyen G.C., Boudreau H., Harris M.L., et al. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009, 7:329-334.
3. Mahadevan U., Sandborn W.J., Li D.K., et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007, 133:1106-1112.
4. Heit J.A., Kobbervig C.E., James A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005, 143:697-706.
5. Kappelman M.D., Horvath-Puho E., Sandler R.S., et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011, 60:937-943.
6. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375:657-663.
7. James A.H. Pregnancy and thrombotic risk. Crit Care Med 2010, 38:S57-S63.
8. Xu J., Lupu F., Esmon C.T. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010, 30:5-6. 8-9.
9. Fox E.A., Kahn S.R. The relationship between inflammation and venous thrombosis: a systematic review of clinical studies. Thromb Haemost 2005, 94:362-365.
10. Johannesdottir S.A., Schmidt M., Horváth-Puhó E., et al. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 2012, 10:815-821.
11. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:381S-453S.
12. Hall D.R. Abruptio placentae and disseminated intravascular coagulopathy. Semin Perinatol 2009, 33:189-195.
13. Ananth C.V., Berkowitz G.S., Savitz D.A., et al. Placental abruption and adverse perinatal outcomes. JAMA 1999, 282:1646-1651.
14. McCormack R.A., Doherty D.A., Magann E.F., et al. Antepartum bleeding of unknown origin in the second half of pregnancy and pregnancy outcomes. BJOG 2008, 115:1451-1457.
15. Buhimschi C.S., Schatz F., Krikun G., et al. Novel insights into molecular mechanisms of abruption-induced preterm birth. Expert Rev Mol Med 2010, 12:e35.
16. Tikkanen M. Etiology, clinical manifestations, and prediction of placental abruption. Acta Obstet Gynecol Scand 2010, 89:732-740.
17. Romero R., Kusanovic J.P., Chaiworapongsa T., et al. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol 2011, 25:313-327.
18. Chakravarty E.F., Nelson L., Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54:899-907.
19. Barnabe C., Faris P.D., Quan H. Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011, 2011:345727.
20. Redman C.W., Sargent I.L. Preeclampsia and the systemic inflammatory response. Semin Nephrol 2004, 24:565-570.
21. Cornish J., Tan E., Teare J., et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007, 56:830-837.
22. Lydon-Rochelle M., Holt V.L., Martin D.P., et al. Association between method of delivery and maternal rehospitalization. JAMA 2000, 283:2411-2416.
23. Ilnyckyji A., Blanchard J.F., Rawsthorne P., et al. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999, 94:3274-3278.
24. Caprilli R., Gassull M.A., Escher J.C., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006, 55(Suppl 1):i36-i58.
25. Smink M., Lotgering F.K., Albers L., et al. Effect of childbirth on the course of Crohn's disease: results from a retrospective cohort study in the Netherlands. BMC Gastroenterol 2011, 11:6.
26. Handa V.L., Blomquist J.L., Knoepp L.R., et al. Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth. Obstet Gynecol 2011, 118:777-784.
27. Nelson R.L., Furner S.E., Westercamp M., et al. Cesarean delivery for the prevention of anal incontinence. Cochrane Database Syst Rev 2010, CD006756.
28. Ong J.P., Edwards G.J., Allison M.C. Mode of delivery and risk of fecal incontinence in women with or without inflammatory bowel disease: questionnaire survey. Inflamm Bowel Dis 2007, 13:1391-1394.
29. Sultan A.H., Kamm M.A., Hudson C.N., et al. Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ 1994, 308:887-891.
30. Cnattingius S., Ericson A., Gunnarskog J., et al. A quality study of a medical birth registry. Scand J Soc Med 1990, 18:143-148.
31. Ludvigsson J.F., Andersson E., Ekbom A., et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11:450.
32. Wettermark B., Hammar N., Fored C.M., et al. The new Swedish Prescribed Drug Register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007, 16:726-735.
33. Stephansson O., Larsson H., Pedersen L., et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis 2011, 17:795-801.
34. Nørgård B., Pedersen L., Christensen L.A., et al. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007, 102:1406-1413.
35. Stephansson O., Granath F., Svensson T., et al. Drug use during pregnancy in Sweden: assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 2011, 3:43-50.